カテゴリー： Market Monitor Global, 世界, 医療/バイオ

前立腺がん診断&治療の世界市場見通し2023年-2029年

◆英語タイトル：Prostate Cancer Diagnostics and Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23LY8611）◆商品コード：MMG23LY8611
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年7月
◆ページ数：60
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Prostate Cancer Diagnostics and Treatment Market 調査レポートは次の情報を含め、グローバルにおけるの前立腺がん診断&治療市場規模と予測を収録しています。・世界の前立腺がん診断&治療市場：売上、2018年-2023年、2024年-2029年
・世界の前立腺がん診断&治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の前立腺がん診断&治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生物学的療法」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

前立腺がん診断&治療のグローバル主要企業は、Tolmar、 Astellas Pharma、 AstraZeneca、 Ferring Pharmaceuticals、 Johnson & Johnson、 Abbott、 Sanofi、 Ipsen、 Novartis、 Bayerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、前立腺がん診断&治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の前立腺がん診断&治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の前立腺がん診断&治療市場：タイプ別市場シェア、2022年
・生物学的療法、化学療法

世界の前立腺がん診断&治療市場：用途別、2018年-2023年、2024年-2029年
世界の前立腺がん診断&治療市場：用途別市場シェア、2022年
・病院、研究機関、診療所

世界の前立腺がん診断&治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の前立腺がん診断&治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における前立腺がん診断&治療のグローバル売上、2018年-2023年
・主要企業における前立腺がん診断&治療のグローバル売上シェア、2022年
・主要企業における前立腺がん診断&治療のグローバル販売量、2018年-2023年
・主要企業における前立腺がん診断&治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Tolmar、 Astellas Pharma、 AstraZeneca、 Ferring Pharmaceuticals、 Johnson & Johnson、 Abbott、 Sanofi、 Ipsen、 Novartis、 Bayer

*************************************************************

・調査・分析レポートの概要
前立腺がん診断&治療市場の定義
市場セグメント
世界の前立腺がん診断&治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の前立腺がん診断&治療市場規模
世界の前立腺がん診断&治療市場規模：2022年 VS 2029年
世界の前立腺がん診断&治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの前立腺がん診断&治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の前立腺がん診断&治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：生物学的療法、化学療法
前立腺がん診断&治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、研究機関、診療所
前立腺がん診断&治療の用途別グローバル売上・予測

・地域別市場分析
地域別前立腺がん診断&治療市場規模 2022年と2029年
地域別前立腺がん診断&治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Tolmar、 Astellas Pharma、 AstraZeneca、 Ferring Pharmaceuticals、 Johnson & Johnson、 Abbott、 Sanofi、 Ipsen、 Novartis、 Bayer
...

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Treatment. This report contains market size and forecasts of Prostate Cancer Diagnostics and Treatment in global, including the following market information:
Global Prostate Cancer Diagnostics and Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnostics and Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biological Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnostics and Treatment include Tolmar, Astellas Pharma, AstraZeneca, Ferring Pharmaceuticals, Johnson & Johnson, Abbott, Sanofi, Ipsen and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Diagnostics and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics and Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, by Type, 2022 (%)
Biological Therapy
Chemotherapy
Global Prostate Cancer Diagnostics and Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institution
Clinic
Global Prostate Cancer Diagnostics and Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Diagnostics and Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics and Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics and Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Diagnostics and Treatment, market overview.
Chapter 2: Global Prostate Cancer Diagnostics and Treatment market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Diagnostics and Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Treatment Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Treatment Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Diagnostics and Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Treatment Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Treatment Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Prostate Cancer Diagnostics and Treatment Market Size Markets, 2022 & 2029
4.1.2 Biological Therapy
4.1.3 Chemotherapy
4.2 By Type – Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
4.2.1 By Type – Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
4.2.2 By Type – Global Prostate Cancer Diagnostics and Treatment Revenue, 2024-2029
4.2.3 By Type – Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prostate Cancer Diagnostics and Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research Institution
5.1.4 Clinic
5.2 By Application – Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
5.2.1 By Application – Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
5.2.2 By Application – Global Prostate Cancer Diagnostics and Treatment Revenue, 2024-2029
5.2.3 By Application – Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Prostate Cancer Diagnostics and Treatment Market Size, 2022 & 2029
6.2 By Region – Global Prostate Cancer Diagnostics and Treatment Revenue & Forecasts
6.2.1 By Region – Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2023
6.2.2 By Region – Global Prostate Cancer Diagnostics and Treatment Revenue, 2024-2029
6.2.3 By Region – Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.3.2 US Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.3 France Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.5.2 China Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.5.6 India Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Diagnostics and Treatment Market Size, 2018-2029
7 Prostate Cancer Diagnostics and Treatment Companies Profiles
7.1 Tolmar
7.1.1 Tolmar Company Summary
7.1.2 Tolmar Business Overview
7.1.3 Tolmar Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.1.4 Tolmar Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.1.5 Tolmar Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.3.4 AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Ferring Pharmaceuticals
7.4.1 Ferring Pharmaceuticals Company Summary
7.4.2 Ferring Pharmaceuticals Business Overview
7.4.3 Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.4.4 Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.4.5 Ferring Pharmaceuticals Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.5.4 Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.6.4 Abbott Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.7.4 Sanofi Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Ipsen
7.8.1 Ipsen Company Summary
7.8.2 Ipsen Business Overview
7.8.3 Ipsen Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.8.4 Ipsen Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.8.5 Ipsen Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.9.4 Novartis Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Prostate Cancer Diagnostics and Treatment Major Product Offerings
7.10.4 Bayer Prostate Cancer Diagnostics and Treatment Revenue in Global Market (2018-2023)
7.10.5 Bayer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Prostate Cancer Diagnostics and Treatment Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics and Treatment Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics and Treatment Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics and Treatment in Global Market
Table 5. Top Prostate Cancer Diagnostics and Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnostics and Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnostics and Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnostics and Treatment Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics and Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnostics and Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Tolmar Company Summary
Table 31. Tolmar Prostate Cancer Diagnostics and Treatment Product Offerings
Table 32. Tolmar Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Tolmar Key News & Latest Developments
Table 34. Astellas Pharma Company Summary
Table 35. Astellas Pharma Prostate Cancer Diagnostics and Treatment Product Offerings
Table 36. Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Pharma Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Prostate Cancer Diagnostics and Treatment Product Offerings
Table 40. AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Ferring Pharmaceuticals Company Summary
Table 43. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Product Offerings
Table 44. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Ferring Pharmaceuticals Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Product Offerings
Table 48. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Prostate Cancer Diagnostics and Treatment Product Offerings
Table 52. Abbott Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Abbott Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Prostate Cancer Diagnostics and Treatment Product Offerings
Table 56. Sanofi Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Ipsen Company Summary
Table 59. Ipsen Prostate Cancer Diagnostics and Treatment Product Offerings
Table 60. Ipsen Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Ipsen Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Prostate Cancer Diagnostics and Treatment Product Offerings
Table 64. Novartis Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Prostate Cancer Diagnostics and Treatment Product Offerings
Table 68. Bayer Prostate Cancer Diagnostics and Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Diagnostics and Treatment Segment by Type in 2022
Figure 2. Prostate Cancer Diagnostics and Treatment Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnostics and Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics and Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics and Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics and Treatment Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Diagnostics and Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Diagnostics and Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Tolmar Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Pharma Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbott Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Ipsen Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novartis Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer Prostate Cancer Diagnostics and Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 前立腺がん診断&治療の世界市場見通し2023年-2029年(Prostate Cancer Diagnostics and Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

※関連リサーチレポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆